Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid

We have begun an early phase of biomarker discovery in three clinically important types of breast cancer using a panel of human cell lines: HER2 positive, HER2 negative and hormone receptor positive and triple negative (HER2−, ER−, PR−). We identified and characterized the most abundant secreted, sl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Whelan, Stephen A., He, Jianbo, Lu, Ming, Souda, Puneet, Saxton, Romaine E., Faull, Kym F., Whitelegge, Julian P., Chang, Helena R.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3521600/
https://ncbi.nlm.nih.gov/pubmed/22934887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/pr300606e
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars